why choose us

First received: August 16, 2023

Clinical Trial: A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Nonalcoholic Fatty Liver Disease (NAFLD)

Study Type: INTERVENTIONAL


Official Title: A Three-Part, Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALN-PNP siRNA in Participants

Brief Summary: This study is researching an experimental drug called ALN-PNP.This study is focused on participants who are known to have nonalcoholic fatty liver disease (NAFLD), and a specific variant of the patatin-like phospholipase domain containing 3 (PNPLA3) gene.The aim of this study is to see how safe, tolerable, and effective the study drug is.This study is looking at several other research questions, including:What side effects may happen from taking the study drugHow the study drug works to change liver fat content in…

Read more